Sacramento, Chester Bittencourt <br/><br/>
Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy.  [electronic resource] 

 -  Human gene therapy  01 2020 
 - 57-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-7422 
<br/><br/><label>Standard No.: </label>10.1089/hum.2019.174  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Brain--metabolism<br/>Chronic Traumatic Encephalopathy--genetics<br/>Dependovirus--genetics<br/>Disease Management<br/>Disease Models, Animal<br/>Disease Susceptibility<br/>Genetic Therapy--adverse effects<br/>Genetic Vectors--genetics<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Neurons--metabolism<br/>Protein Binding<br/>tau Proteins--antagonists & inhibitors